GLOBAL OPHTHALMOLOGY DRUGS MARKET 2018 BY MANUFACTURERS, COUNTRIES, TYPE AND APPLICATION, FORECAST TO 2023

Nov 2018 117

Delivery of the Report will take 2-3 working days once order is placed.

Synopsis

Ophthalmology is a broad therapy area that consists of almost 100 disorders associated with the eyes and visual system, including such diseases as glaucoma, age-related macular degeneration (AMD), diabetic macular edema (DME), diabetic retinopathy (DR) and dry eye syndrome (DES). Many of these disorders are progressive, and if left untreated can lead to severe visual impairment or even blindness.

Scope of the Report:

Of the five key indications within the therapy area - glaucoma, AMD, DME, DR and DES - glaucoma and AMD have the most active product pipelines.

The global Ophthalmology Drugs market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Ophthalmology Drugs.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

This report studies the Ophthalmology Drugs market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Ophthalmology Drugs market by product type and applications/end industries.

Market Segment by Companies, this report covers
- Novartis
- Regeneron
- Roche
- Bayer
- Allergan
- Shire
- Mallinckrodt
- Santen Pharmaceutical
- Aerie

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
- Lucentis (Ranibizumab)
- Eylea (Aflibercept)
- Avastin (Bevacizumab)
- Restasis (Cyclosporine)
- Alphagan (Brimonidine Tartrate)
- Lumigan (Bimatoprost)
- Xalatan (Latanoprost)
- Conclusion

Market Segment by Applications, can be divided into
- Hospital Pharmacies
- Retail Pharmacies
- Drug Stores
- Online Sales

Table of Contents

Related reports :

(Dec 19)

Description Scope of the Report: The worldwide market for Adenosine Triphosphate (ATP) Test Kits is expected to grow a...

(Dec 19)

Description Scope of the Report: The worldwide market for Zirconia Abutment is expected to grow at a CAGR of roughly x...

(Dec 19)

Description Scope of the Report: The worldwide market for Sustained Release Injectables is expected to grow at a CAGR ...

(Dec 19)

Description Scope of the Report: The global Robotics Surgical Simulation Systems market is valued at xx million USD in...

(Dec 19)

Description Scope of the Report: The worldwide market for Trifocal Intraocular Lens is expected to grow at a CAGR of r...

(Dec 19)

Description Scope of the Report: The worldwide market for Continuous Vision Intraocular Lens is expected to grow at a ...

GLOBAL OPHTHALMOLOGY DRUGS MARKET 2018 BY MANUFACTURERS, COUNTRIES, TYPE AND APPLICATION, FORECAST TO 2023

Global Info Research

Share this report on:

Subscription Option


Using our subscription option, you get access to Market Research Reports and industry data of Medical Devices market as per your needs. Get the best of Medical Devices research reports by utilizing your research budgets in an optimum way. Contact for details

Contact for reports

*

We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy